Danan Li
- Oncology top 2%
- HER2/EGFR in Cancer Research 3
- Cancer Cells and Metastasis 2
- Molecular Biology top 5%
- Cancer-related gene regulation 3
- RNA Research and Splicing 3
- PI3K/AKT/mTOR signaling in cancer 2
- RNA modifications and cancer 2
- Cancer Research top 5%
-
- Lung Cancer Treatments and Mutations 9
- Cell Biology top 5%
-
- Quinazolinone synthesis and applications 3
- Co-authors
- Kwok‐Kin WongChad J. CreightonThomas F. WestbrookMichael J. EmanueleJi LuoStephen J. ElledgeMichael R. SchlabachLiang Chen
- Journals
- Cancer Research (7 papers)Clinical Cancer Research (3 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesSingaporeUnited Kingdom
In The Last Decade
Danan Li
19 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 1.6k
- Molecular Biology 2.3k
- Cancer Research 496
- Pulmonary and Respiratory Medicine 1.0k
- Cell Biology 251
Countries citing papers authored by Danan Li
This map shows the geographic impact of Danan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danan Li more than expected).
Fields of papers citing papers by Danan Li
This network shows the impact of papers produced by Danan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danan Li. The network helps show where Danan Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Danan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2017 | 24 | |
| 6 | 2015 | 122 | |
| 7 | 2014 | 72 | |
| 8 | 2012 | 131 | |
| 9 | 2011 | 196 | |
| 10 | 2011 | 224 | |
| 11 | 2011 | 75 | |
| 12 | 2010 | 215 | |
| 13 | 2010 | 99 | |
| 14 | 2010 | 1 | |
| 15 | 2009 | 30 | |
| 16 | Novel mutant-selective EGFR kinase inhibitors against EGFR T790Mbreakdown → | 2009 | 785 |
| 17 | A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogenebreakdown → | 2009 | 779 |
| 18 | 2009 | 247 | |
| 19 | 2007 | 137 | |
| 20 | 2007 | 40 |
About Danan Li
Danan Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 21 papers that have together received 3.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Quinazolinone synthesis and applications (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer-related gene regulation (3 papers), RNA Research and Splicing (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer Cells and Metastasis (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Oncology (1.6k citations), Molecular Biology (2.3k citations) and Cancer Research (496 citations). Danan Li has collaborated with scholars based in United States, Singapore and United Kingdom. Frequent co-authors include Kwok‐Kin Wong, Chad J. Creighton, Thomas F. Westbrook, Michael J. Emanuele, Ji Luo, Stephen J. Elledge, Michael R. Schlabach, Liang Chen, Lucian R. Chirieac and Robert F. Padera. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Journal of Clinical Investigation, Cancer Prevention Research and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.